# Importer of Controlled-Biopharmaceutical (2024-20085) DEA1425 Notice

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/controlled-biopharmaceutical-regulations-2024-importer-compliance/
> **Published:** 2026-03-08T19:45:28-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:26:13-04:00
> **Clinical Summary:** Stay compliant with controlled biopharmaceutical regulations 2024 for importers under DEA standards. Key updates for importers of controlled substances.

---

✦ New

 CED Clinical Relevance
 #70
 Notable Clinical Interest
 Emerging findings or policy developments worth monitoring closely.

⚒ Policy Watch  |  Regulations.gov
PolicyResearchIndustry

💬 Join the Conversation

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

Have thoughts on this? Share it:

 [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Importer+of+Controlled-Biopharmaceutical%282024-20085%29DEA1425+%40drcaplan&url=https%3A%2F%2Fwww.regulations.gov%2Fdocument%2FDEA-2024-0112-0001)
 [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.regulations.gov%2Fdocument%2FDEA-2024-0112-0001)
 [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Importer+of+Controlled-Biopharmaceutical%282024-20085%29DEA1425+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.regulations.gov%2Fdocument%2FDEA-2024-0112-0001)
 [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)
 [📝 Read more on Substack](https://substack.com/@doctorapproved)
 [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)
 

 Related Articles

- [Regulatory Digest 2026-03-06](https://cedclinic.com/regulatory-digest-2026-03-09/)

- [Regulatory Digest 2026-03-06](https://cedclinic.com/controlled-substances-rescheduling-2026/)

- [Regulatory Digest 2026-03-05](https://cedclinic.com/regulatory-cannabis-manufacturing-compliance-2026/)

📰 Source: [https://www.regulations.gov/document/DEA-2024-0112-0001](https://www.regulations.gov/document/DEA-2024-0112-0001)

Further Reading
Research Digest[Daily Digest 2026-03-07](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/)
Evidence Watch[`Cannabinoid Clinical Trials: CBD Cortical Excitability Study`](https://cedclinic.com/cannabidiol-lacks-intrinsic-anti-epileptic-properties-trial/)
CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/)

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I](https://cedclinic.com/synthetic-opioids-schedule-i-placement-butonitazene-flunitazene/)

Detailed regulatory updates on the scheduling of new [controlled substances](https://cedclinic.com/dea-scheduling-cannabis-policy-march-15-2026/) relevant to biopharmaceutical importers and compliance officers.

[Read More](https://cedclinic.com/synthetic-opioids-schedule-i-placement-butonitazene-flunitazene/)

[Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I](https://cedclinic.com/dea-temporary-placement-schedule-i-n-desethyl-isotonitazene/)

Explore temporary scheduling actions impacting controlled biopharmaceutical substances and their import regulations.

[Learn More](https://cedclinic.com/dea-temporary-placement-schedule-i-n-desethyl-isotonitazene/)

[France Sets July Deadline for Medical Cannabis Regulations as Withheld Study Shows …](https://cedclinic.com/france-sets-july-deadline-for-medical-cannabis-regulations-as-withheld-study-shows/)

International regulatory developments in [controlled substances](https://cedclinic.com/dea-scheduling-cannabis-policy-march-15-2026/) including [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) that may influence biopharmaceutical import policies.

[Discover Insights](https://cedclinic.com/france-sets-july-deadline-for-medical-cannabis-regulations-as-withheld-study-shows/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).